If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2002-2007 Postdoctoral training in Hematology and Oncology, Mount Sinai School of Medicine, New York, USA
  • 1997.09-2002.05 Ph.D., in Biology, City University of New York, USA
  • 1994.09-1997.07 M.S., in Biology, City University of New York , USA
  • 1984.09-1988.06 B.S.,  Department of Plant Pathology, National Chung Hsing University

Experience

  • 2018.02- Associate Professor, International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University 
  • 2018.02- Associate Professor, International Ph.D. Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
  • 2016.11-2017.10 Associate Professor, International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University 
  • 2013.02- Associate Professor, Graduate Institute of Medical Sciences, Taipei Medical University
  • 2009.08-2013.07 Assistant Professor, Graduate Institute of Medical Sciences, Taipei Medical University
  • 2009.02-2009.07 Assistant Professor, Institute of Microbiology & Immunology, Chung Shan Medical University
  • 2007.10-2008.10 Research Associate, Hematology and Oncology/Medicine, Mount Sinai School of Medicine, New York, USA
  • 1994-2008 Postdoctoral Fellow, Hematology and Oncology/Medicine, Mount Sinai School of Medicine, New York, USA
  • 1994-2001 Adjunct Lecturer, Biology, Queens College, City University of New York

Awards

  • 2007 Travel Award, ASH 50th Annual Meeting, San Diego, CA

Research Interests

  • Leukocyte trafficking, Cancer biology, Wound healing, Traumatic brain injury

Fingerprint Dive into the research topics where Jungshan Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

  • 921 Citations
  • 13 h-Index
  • 26 Article

High expression of meningioma 1 is correlated with reduced survival rates in colorectal cancer patients

Ho, Y. J., Liu, F. C., Chang, J., Shi, B., Yeh, K. T., Lin, Y. M. & Lu, J. W., Jul 2019, In : Acta Histochemica. 121, 5, p. 628-637 10 p.

Research output: Contribution to journalArticle

  • Open Access
  • 3 Citations (Scopus)

    STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers

    Chang, Y. F., Lim, K. H., Chiang, Y. W., Sie, Z. L., Chang, J., Ho, A. S. & Cheng, C. C., Oct 16 2019, In : BMC Cancer. 19, 1, 959.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Citation (Scopus)

    EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer

    Cheng, C. C., Chou, K. F., Wu, C. W., Su, N. W., Peng, C. L., Su, Y. W., Chang, J., Ho, A. S., Lin, H. C., Chen, C. G. S., Yang, B. L., Chang, Y. C., Chiang, Y. W., Lim, K. H. & Chang, Y. F., Feb 1 2018, In : Lung Cancer. 116, p. 80-89 10 p.

    Research output: Contribution to journalArticle

  • 8 Citations (Scopus)

    Epidermal growth factor induces STAT1 expression to exacerbate the IFNr-mediated PD-L1 axis in epidermal growth factor receptor-positive cancers

    Cheng, C. C., Lin, H. C., Tsai, K. J., Chiang, Y. W., Lim, K. H., Chen, C. G. S., Su, Y. W., Peng, C. L., Ho, A. S., Huang, L., Chang, Y. C., Lin, H. C., Chang, J. & Chang, Y. F., Nov 1 2018, In : Molecular Carcinogenesis. 57, 11, p. 1588-1598 11 p.

    Research output: Contribution to journalArticle

  • 9 Citations (Scopus)